- Intel faces a shareholder lawsuit over a controversial grant of a 10% stake to the US government.
- The lawsuit claims the transaction was coerced by fears of retaliation from the Trump administration.
- The deal, made in August 2025, has been described as an attempt to protect the reputations of Intel’s leadership.
- Intel’s shares have nearly doubled in value since the government’s investment.
- The suit also implicates the US Department of Commerce and prominent legal firms in the alleged misconduct.
Intel Corporation finds itself embroiled in a significant legal dispute as a shareholder lawsuit emerges, accusing its leadership of capitulating to pressure from the Trump administration. The lawsuit, initiated by Richard Paisner, a small investor, contends that a deal struck in August 2025, granting the US government a substantial 10% stake in the company, was both unlawful and unbeneficial to shareholders.
Describing the arrangement as an “unlawful contract that gives the US government $11bn worth of Intel stock for no meaningful consideration,” the lawsuit highlights the unprecedented ways the Trump administration sought to intertwine federal interests with private enterprise. This report underscores concerns regarding the protection of corporate leadership amid perceived threats, as the lawsuit asserts that Intel’s board members acted out of fear for their reputations, seeking to avoid potential public scorn from Trump and his supporters.
In a striking turn of events, Intel’s CEO Lip-Bu Tan faced public disdain from Trump, who, in a 2025 address, publicly called for Tan’s resignation. The attack stemmed from inquiries about Tan’s past investments in Chinese firms, which drew the ire of Republican lawmakers. Following Trump’s remarks, Tan made an unplanned visit to the White House, which ultimately led to the announcement that the US would acquire its stake in Intel.
This government equity position has been funded through grants tied to the Biden-era Chips Act, converting $2.2bn in federal incentives and $8.9bn in unallocated federal funds into a government holding in Intel. The lawsuit alleges this agreement was a strategic move to ensure Tan’s continued leadership at Intel.
Moreover, the case progresses to implicate legal representation from Skadden, a major law firm, which allegedly failed to act impartially amidst the government’s overreach. While Skadden is not named as a defendant in the lawsuit, its prior engagement to provide pro bono legal advice to the Trump administration raises questions about conflicts of interest.
As the case unfolds in the Delaware Court of Chancery, Intel’s stock performance tells a different story. The company’s share prices have skyrocketed since the government investment, now boasting a market capitalization nearing $250bn. This inversion of fortunes brings focus to the board’s decisions, prompting market analysts to scrutinize whether these actions were truly in the best interests of shareholders.
Following a turbulent tenure, following the ousting of former CEO Pat Gelsinger, Tan’s leadership has faced challenges, marked by significant financial losses in Intel’s foundry business. The ongoing debate surrounding the balance between national interests and corporate autonomy remains a central theme as Intel navigates its future amid controversy.
The murky waters of government involvement in private industry pose essential questions about how far authorities can go in influencing corporate actions, especially in sectors deemed critical to national security.
An interesting fact to consider: The semiconductor industry has become a focal point in global trade discussions, emphasizing the ongoing geopolitical tensions surrounding technology and manufacturing capabilities.
For more details, visit Financial Times.
